Petra Mazzocchetti
Perugia, 06156, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits.
Journal: International journal of molecular sciences
Published: January 01, 2024
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson's Disease: Lessons From LRRK2.
Journal: Frontiers in cellular neuroscience
Published: January 08, 2020
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease.
Journal: Neuropharmacology
Published: October 25, 2019
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition.
Journal: Neurobiology of disease
Published: August 01, 2019
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions.
Journal: Cephalalgia : an international journal of headache
Published: March 30, 2019
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences.
Journal: Current neuropharmacology
Published: October 25, 2018
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: September 05, 2018
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration.
Journal: Brain : a journal of neurology
Published: April 30, 2018
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease.
Journal: Neurobiology of disease
Published: March 09, 2018
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity.
Journal: Neuropharmacology
Published: November 08, 2017
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease.
Journal: Cell death & disease
Published: September 04, 2017
Last Updated: 09/26/2026